BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y. MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 2011;129:2611-20. [PMID: 21225631 DOI: 10.1002/ijc.25923] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Yanaihara N, Noguchi Y, Saito M, Takenaka M, Takakura S, Yamada K, Okamoto A. MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma. PLoS One 2016;11:e0162584. [PMID: 27612152 DOI: 10.1371/journal.pone.0162584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
2 Zhang W, Tao Z, Xu F, Diao Q, Li J, Zhou L, Miao Y, Xie S, Wan J, Xu R. An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension. Biomed Res Int 2021;2021:5765029. [PMID: 34660794 DOI: 10.1155/2021/5765029] [Reference Citation Analysis]
3 Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W, He ML, Kung H, Li XP. miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis 2014;35:554-63. [PMID: 24170200 DOI: 10.1093/carcin/bgt354] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
4 Suzuki H, Maruyama R, Yamamoto E, Niinuma T, Kai M. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer. In: Song E, editor. The Long and Short Non-coding RNAs in Cancer Biology. Singapore: Springer; 2016. pp. 109-35. [DOI: 10.1007/978-981-10-1498-7_4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chen H, Feng Z, Li L, Fan L. MicroRNA-9 rescues hyperglycemia-induced endothelial cell dysfunction and promotes arteriogenesis through downregulating Notch1 signaling. Mol Cell Biochem 2021;476:2777-89. [PMID: 33721156 DOI: 10.1007/s11010-021-04075-8] [Reference Citation Analysis]
6 Li K, Wan CL, Guo Y. Circular RNA circMTO1 Suppresses RCC Cancer Cell Progression via miR9/LMX1A Axis. Technol Cancer Res Treat 2020;19:1533033820914286. [PMID: 32207384 DOI: 10.1177/1533033820914286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Wang L, Ma L, Fan H, Yang Z, Li L, Wang H. MicroRNA-9 regulates cardiac fibrosis by targeting PDGFR-β in rats. J Physiol Biochem 2016;72:213-23. [PMID: 26896308 DOI: 10.1007/s13105-016-0471-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
8 Yan L, Sun K, Liu Y, Liang J, Cai K, Gui J. MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1. Tumour Biol 2017;39:1010428317706916. [PMID: 28653880 DOI: 10.1177/1010428317706916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
9 Ma J, Li X. MicroRNAs are involved in the toxicity of microcystins. Toxin Reviews 2016;36:165-75. [DOI: 10.1080/15569543.2016.1258713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
10 Maruyama R, Suzuki H, Yamamoto E, Imai K, Shinomura Y. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer. Tumour Biol 2012;33:277-85. [PMID: 22219034 DOI: 10.1007/s13277-011-0308-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
11 Yan JW, Lin JS, He XX. The emerging role of miR-375 in cancer. Int J Cancer. 2014;135:1011-1018. [PMID: 24166096 DOI: 10.1002/ijc.28563] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 15.7] [Reference Citation Analysis]
12 Missiaglia E, Shepherd CJ, Aladowicz E, Olmos D, Selfe J, Pierron G, Delattre O, Walters Z, Shipley J. MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas. Cancer Lett 2017;385:251-60. [PMID: 27984116 DOI: 10.1016/j.canlet.2016.10.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
13 Han D, Li J, Wang H, Su X, Hou J, Gu Y, Qian C, Lin Y, Liu X, Huang M, Li N, Zhou W, Yu Y, Cao X. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66:1151-1164. [PMID: 28520103 DOI: 10.1002/hep.29270] [Cited by in Crossref: 606] [Cited by in F6Publishing: 639] [Article Influence: 121.2] [Reference Citation Analysis]
14 Rahimian N, Razavi ZS, Aslanbeigi F, Mirkhabbaz AM, Piroozmand H, Shahrzad MK, Hamblin MR, Mirzaei H. Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecol Oncol 2021;161:896-912. [PMID: 33781555 DOI: 10.1016/j.ygyno.2021.03.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
16 Tian W, Pang X, Luan F. Diagnosis value of miR-181, miR-652, and CA72-4 for gastric cancer. J Clin Lab Anal 2022;:e24411. [PMID: 35446997 DOI: 10.1002/jcla.24411] [Reference Citation Analysis]
17 Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB. MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol 2011;8:557-64. [PMID: 21697652 DOI: 10.4161/rna.8.4.16019] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
18 Suzuki H, Maruyama R, Yamamoto E, Kai M. Epigenetic alteration and microRNA dysregulation in cancer. Front Genet. 2013;4:258. [PMID: 24348513 DOI: 10.3389/fgene.2013.00258] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 10.4] [Reference Citation Analysis]
19 Nishiuchi A, Hisamori S, Sakaguchi M, Fukuyama K, Hoshino N, Itatani Y, Honma S, Maekawa H, Nishigori T, Tsunoda S, Obama K, Miyoshi H, Shimono Y, Taketo MM, Sakai Y. MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer. Cancers (Basel) 2019;11:E1891. [PMID: 31783700 DOI: 10.3390/cancers11121891] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Khafaei M, Rezaie E, Mohammadi A, Shahnazi Gerdehsang P, Ghavidel S, Kadkhoda S, Zorrieh Zahra A, Forouzanfar N, Arabameri H, Tavallaie M. miR-9: From function to therapeutic potential in cancer. J Cell Physiol 2019. [PMID: 30693512 DOI: 10.1002/jcp.28210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
21 Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, Lin A, Shu Q, Zhou T. Non-coding RNAs in gastric cancer. Cancer Lett 2020;493:55-70. [PMID: 32712234 DOI: 10.1016/j.canlet.2020.06.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 2013;7:220. [PMID: 24312010 DOI: 10.3389/fncel.2013.00220] [Cited by in Crossref: 162] [Cited by in F6Publishing: 152] [Article Influence: 18.0] [Reference Citation Analysis]
23 Shang A, Lu WY, Yang M, Zhou C, Zhang H, Cai ZX, Wang WW, Wang WX, Wu GQ. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway. Artif Cells Nanomed Biotechnol 2018;46:1754-62. [PMID: 29073835 DOI: 10.1080/21691401.2017.1391825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
24 Wang S, Wu W, Claret FX. Mutual regulation of microRNAs and DNA methylation in human cancers. Epigenetics. 2017;12:187-197. [PMID: 28059592 DOI: 10.1080/15592294.2016.1273308] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
25 Yu S, Liu X, Zhang Y, Li J, Chen S, Zheng H, Reng R, Zhang C, Chen J, Chen L. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Oncotarget 2016;7:84165-77. [PMID: 27705935 DOI: 10.18632/oncotarget.12389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
26 Xia J, Guo X, Deng K. Epigenetics, MicroRNAs and Human Cancer. In: Babashah S, editor. MicroRNAs: Key Regulators of Oncogenesis. Cham: Springer International Publishing; 2014. pp. 29-57. [DOI: 10.1007/978-3-319-03725-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X. Molecular mechanisms of Barrett's esophagus. Dig Dis Sci 2011;56:3405-20. [PMID: 21984436 DOI: 10.1007/s10620-011-1885-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
28 Coolen M, Bally-Cuif L. [miR-9: a key factor of the physiopathological regulation of the neural progenitor state]. Med Sci (Paris) 2013;29:1010-7. [PMID: 24280505 DOI: 10.1051/medsci/20132911018] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Tuna M, Machado AS, Calin GA. Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes Cancer 2016;55:193-214. [PMID: 26651018 DOI: 10.1002/gcc.22332] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
30 Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol 2018;15:338-52. [PMID: 29570036 DOI: 10.1080/15476286.2018.1445959] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
31 Yao R, Zou H, Liao W. Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target. Front Oncol. 2018;8:332. [PMID: 30191143 DOI: 10.3389/fonc.2018.00332] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
32 Fenger JM, Bear MD, Volinia S, Lin TY, Harrington BK, London CA, Kisseberth WC. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer. 2014;14:84. [PMID: 24517413 DOI: 10.1186/1471-2407-14-84] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
33 Tritto V, Ferrari L, Esposito S, Zuccotti P, Bianchessi D, Natacci F, Saletti V, Eoli M, Riva P. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients. Genes (Basel) 2019;10:E892. [PMID: 31694342 DOI: 10.3390/genes10110892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Tian SB, Yu JC, Liu YQ, Kang WM, Ma ZQ, Ye X, Yan C. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol 2015; 21(31): 9337-9347 [PMID: 26309359 DOI: 10.3748/wjg.v21.i31.9337] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
35 Lima JF, Carvalho J, Pinto-Ribeiro I, Almeida C, Wengel J, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides. BMC Mol Biol 2018;19:6. [PMID: 29879907 DOI: 10.1186/s12867-018-0107-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
36 Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Oncogene 2014;33:5017-27. [DOI: 10.1038/onc.2013.448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 8.2] [Reference Citation Analysis]
37 Braga EA, Khodyrev DS, Loginov VI, Pronina IV, Senchenko VN, Dmitriev AA, Kubatiev AA, Kushlinskii NE. Methylation in the regulation of the expression of chromosome 3 and microRNA genes in clear-cell renal cell carcinomas. Russ J Genet 2015;51:566-81. [DOI: 10.1134/s1022795415050026] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
38 Chen J, Wu L, Sun Y, Yin Q, Chen X, Liang S, Meng Q, Long H, Li F, Luo C, Xiao X. Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer. PeerJ 2019;7:e7002. [PMID: 31245174 DOI: 10.7717/peerj.7002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
39 Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem. 2012;287:29516-29528. [PMID: 22761433 DOI: 10.1074/jbc.m111.335943] [Cited by in Crossref: 128] [Cited by in F6Publishing: 88] [Article Influence: 12.8] [Reference Citation Analysis]
40 Li H, Wu Q, Li T, Liu C, Xue L, Ding J, Shi Y, Fan D. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review. Oncotarget 2017;8:45060-71. [PMID: 28178677 DOI: 10.18632/oncotarget.15023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
41 Yang Q, Zhang RW, Sui PC, He HT, Ding L. Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol 2015; 21(39): 10956-10981 [PMID: 26494954 DOI: 10.3748/wjg.v21.i39.10956] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
42 Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 2014;1845:255-265. [PMID: 24569228 DOI: 10.1016/j.bbcan.2014.02.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 96] [Article Influence: 4.8] [Reference Citation Analysis]
43 Ao R, Wang Y, Tong J, Wang BF. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Med Sci Monit. 2016;22:3804-3819. [PMID: 27756894 DOI: 10.12659/msm.897207] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
44 Chen X, Zhu L, Ma Z, Sun G, Luo X, Li M, Zhai S, Li P, Wang X. Oncogenic miR-9 is a target of erlotinib in NSCLCs. Sci Rep 2015;5:17031. [PMID: 26593208 DOI: 10.1038/srep17031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
45 Van den Hove DL, Kompotis K, Lardenoije R, Kenis G, Mill J, Steinbusch HW, Lesch K, Fitzsimons CP, De Strooper B, Rutten BP. Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiology of Aging 2014;35:731-45. [DOI: 10.1016/j.neurobiolaging.2013.10.082] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 9.4] [Reference Citation Analysis]
46 Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20(30): 10432-10439 [PMID: 25132759 DOI: 10.3748/wjg.v20.i30.10432] [Cited by in CrossRef: 152] [Cited by in F6Publishing: 154] [Article Influence: 19.0] [Reference Citation Analysis]
47 Zhou S, Tang X, Tang F. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis. Tumour Biol 2016;37:1505-13. [PMID: 26662959 DOI: 10.1007/s13277-015-4588-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
48 Khodyrev DS, Pronina IV, Rykov SV, Beresneva EV, Freedman MV, Kazubskaya TP, Loginov VI, Braga EA. Involvement of methylation of group of miRNA genes in regulation of expression of RAR-beta2 and NKIRAS1 target genes in lung cancer. Mol Biol 2012;46:693-704. [DOI: 10.1134/s002689331205007x] [Cited by in Crossref: 10] [Article Influence: 1.0] [Reference Citation Analysis]
49 Shan F, Li J, Huang QY. HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia. J Cell Physiol 2014;229:1511-20. [PMID: 24615545 DOI: 10.1002/jcp.24593] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
50 Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4:279-294. [PMID: 22690664 DOI: 10.2217/epi.12.22] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
51 Shirmohammadi K, Sohrabi S, Jafarzadeh Samani Z, Effatpanah H, Yadegarazari R, Saidijam M. Evaluation of altered expression of miR-9 and miR-106a as an early diagnostic approach in gastric cancer. J Gastrointest Oncol 2018;9:46-51. [PMID: 29564170 DOI: 10.21037/jgo.2017.11.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C, Zhao RC. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol. 2013;7:884-894. [PMID: 23684102 DOI: 10.1016/j.molonc.2013.04.007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
53 Karimzadeh MR, Pourdavoud P, Ehtesham N, Qadbeigi M, Asl MM, Alani B, Mosallaei M, Pakzad B. Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy. Cancer Gene Ther 2021;28:157-74. [PMID: 32773776 DOI: 10.1038/s41417-020-00210-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Zou L, Xiong X, Yang H, Wang K, Zhou J, Lv D, Yin Y. Identification of microRNA transcriptome reveals that miR-100 is involved in the renewal of porcine intestinal epithelial cells. Sci China Life Sci 2019;62:816-28. [PMID: 31016537 DOI: 10.1007/s11427-018-9338-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
55 Busch M, Dünker N. Trefoil factor family peptides – friends or foes? Biomolecular Concepts 2015;6:343-59. [DOI: 10.1515/bmc-2015-0020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
56 Kaur S, Lotsari-Salomaa JE, Seppänen-Kaijansinkko R, Peltomäki P. MicroRNA Methylation in Colorectal Cancer. Adv Exp Med Biol 2016;937:109-22. [PMID: 27573897 DOI: 10.1007/978-3-319-42059-2_6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
57 Brzuzan P, Woźny M, Wolińska L, Piasecka A. Expression profiling in vivo demonstrates rapid changes in liver microRNA levels of whitefish (Coregonus lavaretus) following microcystin-LR exposure. Aquat Toxicol 2012;122-123:188-96. [PMID: 22819808 DOI: 10.1016/j.aquatox.2012.07.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
58 Choi JM, Kim SG. Effect of Helicobacter pylori Eradication on Epigenetic Changes in Gastric Cancer-related Genes. Korean J Helicobacter Up Gastrointest Res 2021;21:256-66. [DOI: 10.7704/kjhugr.2021.0042] [Reference Citation Analysis]
59 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
60 Noto JM, Peek RM. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol. 2011;1:21. [PMID: 22919587 DOI: 10.3389/fcimb.2011.00021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
61 Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther 2014;21:305-16. [PMID: 25060632 DOI: 10.1038/cgt.2014.37] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
62 Wang HB, Wei H, Wang JS, Li L, Chen AY, Li ZG. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway. Biochim Biophys Acta Mol Basis Dis 2019;1865:708-23. [PMID: 30611858 DOI: 10.1016/j.bbadis.2019.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
63 Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M, Tan P. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation: MicroRNA dysregulation in gastric cancer. Int J Cancer 2016;138:1337-49. [DOI: 10.1002/ijc.29627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
64 Khosravi A, Alizadeh S, Jalili A, Shirzad R, Saki N. The impact of Mir-9 regulation in normal and malignant hematopoiesis. Oncol Rev 2018;12:348. [PMID: 29774136 DOI: 10.4081/oncol.2018.348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA methylation and microRNA dysregulation in cancer. Mol Oncol. 2012;6:567-578. [PMID: 22902148 DOI: 10.1016/j.molonc.2012.07.007] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 16.0] [Reference Citation Analysis]
66 Masliah-Planchon J, Pasmant E, Luscan A, Laurendeau I, Ortonne N, Hivelin M, Varin J, Valeyrie-Allanore L, Dumaine V, Lantieri L, Leroy K, Parfait B, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis. BMC Genomics 2013;14:473. [PMID: 23848554 DOI: 10.1186/1471-2164-14-473] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
67 Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35-47.e2. [PMID: 22580099 DOI: 10.1053/j.gastro.2012.05.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
68 Zhang J, Jia J, Zhao L, Li X, Xie Q, Chen X, Wang J, Lu F. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Mol Carcinog 2016;55:732-42. [PMID: 25809226 DOI: 10.1002/mc.22317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
69 Beresneva EV, Rykov SV, Khodyrev DS, Pronina IV, Ermilova VD, Kazubskaya TP, Braga EA, Loginov VI. Methylation profile of group of miRNA genes in clear cell renal cell carcinoma and their involvement in cancer progression. Russ J Genet 2013;49:320-8. [DOI: 10.1134/s1022795413030034] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
70 Yi J, Gao ZF. MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4. Int J Biol Macromol 2019;130:1-9. [PMID: 30716366 DOI: 10.1016/j.ijbiomac.2019.02.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
71 Senyuk V, Zhang Y, Liu Y, Ming M, Premanand K, Zhou L, Chen P, Chen J, Rowley JD, Nucifora G, Qian Z. Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis. Proc Natl Acad Sci U S A 2013;110:5594-9. [PMID: 23509296 DOI: 10.1073/pnas.1302645110] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
72 Castillo D, Puig S, Iglesias M, Seoane A, de Bolós C, Munitiz V, Parrilla P, Comerma L, Poulsom R, Krishnadath KK, Grande L, Pera M. Activation of the BMP4 Pathway and Early Expression of CDX2 Characterize Non-specialized Columnar Metaplasia in a Human Model of Barrett’s Esophagus. J Gastrointest Surg 2012;16:227-37. [DOI: 10.1007/s11605-011-1758-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
73 Ding J, Zhou W, Li X, Sun M, Ding J, Zhu Q. Tandem DNAzyme for double digestion: a new tool for circRNA suppression. Biological Chemistry 2019;400:247-53. [DOI: 10.1515/hsz-2018-0232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
74 Mohammadian F, Pilehvar-soltanahmadi Y, Zarghami F, Akbarzadeh A, Zarghami N. Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 2017;45:1201-6. [DOI: 10.1080/21691401.2016.1216854] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
75 Zhang HW, Shi Y, Liu JB, Wang HM, Wang PY, Wu ZJ, Li L, Gu LP, Cao PS, Wang GR, Ma YS, Fu D. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis. J Cell Mol Med 2021;25:3699-713. [PMID: 33621425 DOI: 10.1111/jcmm.15765] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Samadani AA, Nikbakhsh N, Pilehchian M, Fattahi S, Akhavan-Niaki H. Epigenetic changes of CDX2 in gastric adenocarcinoma. J Cell Commun Signal 2016;10:267-72. [PMID: 27139434 DOI: 10.1007/s12079-016-0327-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
77 Munoz JL, Rodriguez-Cruz V, Walker ND, Greco SJ, Rameshwar P. Temozolomide resistance and tumor recurrence: Halting the Hedgehog. Cancer Cell Microenviron 2015;2:e747. [PMID: 27158638 DOI: 10.14800/ccm.747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
78 Guinde J, Benoit A, Frankel D, Robert S, Ostacolo K, Lévy N, Astoul P, Roll P, Kaspi E. miR-9 Does Not Regulate Lamin A Expression in Metastatic Cells from Lung Adenocarcinoma. Int J Mol Sci 2020;21:E1599. [PMID: 32111074 DOI: 10.3390/ijms21051599] [Reference Citation Analysis]
79 Kiani S, Akhavan-niaki H, Fattahi S, Kavoosian S, Babaian Jelodar N, Bagheri N, Najafi Zarrini H. Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells. Gene 2018;678:115-23. [DOI: 10.1016/j.gene.2018.08.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
80 Yong H, Fu J, Gao G, Shi H, Zheng D, Zhou X. MiR-34a suppresses the proliferation and invasion of gastric cancer by modulating PDL1 in the immune microenvironment. Molecular and Cellular Probes 2020;53:101601. [DOI: 10.1016/j.mcp.2020.101601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Lewis A, Lee JY, Donaldson AV, Natanek SA, Vaidyanathan S, Man WD, Hopkinson NS, Sayer AA, Patel HP, Cooper C, Syddall H, Polkey MI, Kemp PR. Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD. J Cachexia Sarcopenia Muscle 2016;7:330-44. [PMID: 27239417 DOI: 10.1002/jcsm.12078] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
82 Bahrami A, Jafari A, Ferns GA. The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor? Biomed Pharmacother 2021;145:112394. [PMID: 34781141 DOI: 10.1016/j.biopha.2021.112394] [Reference Citation Analysis]
83 Gil-Gómez G, Fassan M, Nonell L, Garrido M, Climent M, Anglada R, Iglesias M, Guzzardo V, Borga C, Grande L, de Bolós C, Pera M. miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus. Dis Esophagus 2021;34:doab005. [PMID: 33558874 DOI: 10.1093/dote/doab005] [Reference Citation Analysis]
84 Krishn SR, Batra SK, Kaur S. Advances in miRNA-Mediated Mucin Regulation. Curr Pharmacol Rep 2015;1:355-64. [PMID: 27867838 DOI: 10.1007/s40495-014-0010-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
85 Chai D, Du H, Li K, Zhang X, Li X, Zhao X, Lian X, Xu Y. CDX2 and Reg IV expression and correlation in gastric cancer. BMC Gastroenterol 2021;21:92. [PMID: 33639844 DOI: 10.1186/s12876-021-01678-9] [Reference Citation Analysis]
86 Lin M, Huang D, Deng B, Lv Y, Rong L, Yao Y. Expression and Functional Role of Cdx2 in Intestinal Metaplasia of Cystitis Glandularis. Journal of Urology 2013;190:1083-9. [DOI: 10.1016/j.juro.2013.03.109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
87 Kang C, Song JJ, Lee J, Kim MY. Epigenetics: An emerging player in gastric cancer. World J Gastroenterol 2014; 20(21): 6433-6447 [PMID: 24914365 DOI: 10.3748/wjg.v20.i21.6433] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
88 Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 2015;22:291-301. [DOI: 10.1038/cgt.2015.19] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
89 Yin H, He H, Shen X, Zhao J, Cao X, Han S, Cui C, Chen Y, Wei Y, Xia L, Wang Y, Li D, Zhu Q. miR-9-5p Inhibits Skeletal Muscle Satellite Cell Proliferation and Differentiation by Targeting IGF2BP3 through the IGF2-PI3K/Akt Signaling Pathway. Int J Mol Sci 2020;21:E1655. [PMID: 32121275 DOI: 10.3390/ijms21051655] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
90 Tagawa T, Haraguchi T, Hiramatsu H, Kobayashi K, Sakurai K, Inada K, Iba H. Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells. Biochem J 2012;447:449-55. [PMID: 22849325 DOI: 10.1042/BJ20120434] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
91 Calcagno DQ, de Arruda Cardoso Smith M, Burbano RR. Cancer type-specific epigenetic changes: gastric cancer. Methods Mol Biol. 2015;1238:79-101. [PMID: 25421656 DOI: 10.1007/978-1-4939-1804-1_5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
92 Radhakrishnan B, Alwin Prem Anand A. Role of miRNA-9 in Brain Development. J Exp Neurosci 2016;10:101-20. [PMID: 27721656 DOI: 10.4137/JEN.S32843] [Cited by in Crossref: 49] [Cited by in F6Publishing: 29] [Article Influence: 8.2] [Reference Citation Analysis]
93 Gan GL, Liu J, Chen WJ, Ye QQ, Xu Y, Wu HT, Li W. The Diverse Roles of the Mucin Gene Cluster Located on Chromosome 11p15.5 in Colorectal Cancer. Front Cell Dev Biol. 2020;8:514. [PMID: 32695780 DOI: 10.3389/fcell.2020.00514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
94 Xu X, Zou H, Luo L, Wang X, Wang G. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2. FEBS Open Bio 2019;9:1784-97. [PMID: 31408273 DOI: 10.1002/2211-5463.12716] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
95 Zheng L, Qi T, Yang D, Qi M, Li D, Xiang X, Huang K, Tong Q. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One 2013;8:e55719. [PMID: 23383271 DOI: 10.1371/journal.pone.0055719] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 10.6] [Reference Citation Analysis]